Immunization with recombinant accessory protein-deficient SARS-CoV-2 protects against lethal challenge and viral transmission
C. Ye, J.-G. Park, K. Chiem, P. Dravid, A. Allue Guardia, A. Garcia-Vilanova, A. kapoor, M. R. Walter, J. Kobie, R. K. Plemper, J. B. Torrelles, L. Martinez-Sobrido
This study develops a live-attenuated SARS-CoV-2 vaccine by deleting two accessory proteins, showing it protects against viral challenge and transmission in animal models.
bioRxiv · Mar 13, 2022 · PreprintMicrobiology